QNTM: Quantum BioPharma Company Aggregate Debts

Symbol and logo of brand Quantum BioPharma Ltd. (QNTM)

The aggregate creditor burden clearly demonstrates the dynamics of borrowed capital, while 0.00 determines the current status of the parameter. Quantum BioPharma Ltd (QNTM) faces regulatory skepticism and legal risks within the biologics sector. Meanwhile, the company is developing unique formulas for treating rare skin pathologies. Environmental policy relies on standard laboratory waste control and basic safety.

Quantum BioPharma Ltd - QNTM Company Debts (period 08/16/2024 - 10/28/2026)

Analytical breakdowns and data insights for company Quantum BioPharma (QNTM)

- price and consensus price forecast:
Price Performance Chart Quantum BioPharma Corp|QNTM - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Quantum BioPharma Limited|QNTM - Total Company Value
- book capitalization data:
Accounting Value of a Share Quantum BioPharma|QNTM - Company Book Value|Market Cap to Net Assets Ratio quantumbiopharma.com|QNTM - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Quantum BioPharma Ltd|QNTM - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Quantum BioPharma Ltd.|QNTM - Company Debts|Debts to Book Value Quantum BioPharma Limited
Fundamental company valuation:QNTM (Quantum BioPharma Corp)
Original product of Quantum BioPharma Ltd.

The stability of Quantum BioPharma Ltd (QNTM) is based on attracting highly qualified personnel to develop innovations, which requires significant capital expenditures. This metric captures the total volume of borrowed obligations, allowing investors via GURU.Markets to compare the pace of credit expansion with margin growth to determine, based on the level of financial debt, whether business scaling is turning into a dangerous debt dependency.

Analysis of competing companies

Aggregate Debt Obligations Haleon Corp (HLN)|Company Aggregate Debts KVUE (Kenvue Inc.)|veronapharma.com - Company Aggregate Debts|Company Debts Jyong Biotech (MENS)|LGND: Aggregate Debt Obligations|AMRX (Amneal Pharmaceuticals Inc) - Company Debts|Perrigo Corp (PRGO) - Company Total Debt|ALVO (Alvotech) - Company Aggregate Debts|Company Aggregate Debts liquidia.com (LQDA)|Galapagos (GLPG) - Company Total Debt|Aggregate Debt Obligations ANIP (ANI Pharmaceuticals Inc)|MNKD: Company Debts|AMPH - Company Cumulative Debt|Company Total Debt Pacira BioSciences PCRX|SPRY - Company Cumulative Indebtedness|Company Aggregate Debts Theravance Biopharma, Inc. TBPH|Aquestive Therapeutics Inc (AQST) - Aggregate Debt Obligations|Company Aggregate Debts SCPH (scPharmaceuticals, Inc.)|Company Cumulative Debt TECX|Tonix Pharmaceuticals (TNXP) - Company Debts|Aggregate Debt Obligations SXTC (sxtchina.com)|EPRX (Eupraxia Pharmaceuticals Inc.) - Company Debts|BHST - Company Total Indebtedness|Invizyne Technologies, Inc. - Company Total Debt|ORMP - Company Aggregate Debts|ENTX: Company Aggregate Debts|HYFT (ipatherapeutics.com) - Company Aggregate Debts|Company Debts ABVC BioPharma, Inc. (ABVC)|Company Aggregate Debt Cumberland Pharmaceuticals Inc (CPIX)|Company Total Debt FibroGen Corp|Company Cumulative Indebtedness Telomir Pharmaceuticals Corp TELO|Company Total Debt RANI (Rani Therapeutics Holdings, Inc.)|Synergy CHC Corp. - Company Aggregate Debts|RLYB: Company Debts|Lexaria Bioscience (LEXX) - Company Total Debt|Company Total Debt Pulmatrix Corp PULM|Pheton Holdings (PTHL) - Aggregate Debt Obligations|Company Aggregate Debts Aptorum Group Ltd|Company Debts lyratherapeutics.com|IBO (Impact BioMedical) - Company Aggregate Debts|Company Total Debt Obligations TNFA (tnfpharma.com)|YCBD: Company Debts|PainReform Corp - Company Cumulative Debt|Company Debts Auris Medical|LIPO - Company Aggregate Indebtedness|Company Aggregate Debts OptiNose OPTN|Pieris Pharmaceuticals Inc (PIRS) - Aggregate Debt Obligations|PROC (Procaps Group SA) - Company Aggregate Debts|Company Aggregate Debts PTPI|Qilian International (QLI) - Company Debts|Aggregate Debt Obligations SLRN (acelyrin.com)|TFF Pharmaceuticals, Inc. - Company Debts